This cross comparison demonstrates that the biomarker construction which maximises DUX4 target gene discriminatory power in FSHD focuses only on upregulated targets, while that which maximises PAX7 target gene discriminatory power utilises both upregulated and downregulated target genes. This evidence concerns the gene PAX7 and facioscapulohumeral muscular dystrophy.